These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 11425243

  • 1. Differential diagnosis of prostate cancer and benign prostate hyperplasia using two-dimensional electrophoresis.
    Charrier JP, Tournel C, Michel S, Comby S, Jolivet-Reynaud C, Passagot J, Dalbon P, Chautard D, Jolivet M.
    Electrophoresis; 2001 May; 22(9):1861-6. PubMed ID: 11425243
    [Abstract] [Full Text] [Related]

  • 2. Two-dimensional electrophoresis of prostate-specific antigen in sera of men with prostate cancer or benign prostate hyperplasia.
    Charrier JP, Tournel C, Michel S, Dalbon P, Jolivet M.
    Electrophoresis; 1999 May; 20(4-5):1075-81. PubMed ID: 10344287
    [Abstract] [Full Text] [Related]

  • 3. Free to total prostate-specific antigen (PSA) ratio is superior to total-PSA in differentiating benign prostate hypertrophy from prostate cancer.
    Van Cangh PJ, De Nayer P, Sauvage P, Tombal B, Elsen M, Lorge F, Opsomer R, Wese FX.
    Prostate Suppl; 1996 May; 7():30-4. PubMed ID: 8950361
    [Abstract] [Full Text] [Related]

  • 4. [Free/total prostate specific antigen ratio (%PSA) to predict probability of prostate cancer].
    Zenimoto M, Kita M, Arai T, Murayama T, Mori M.
    Rinsho Byori; 2003 Oct; 51(10):969-73. PubMed ID: 14653195
    [Abstract] [Full Text] [Related]

  • 5. Prostate specific antigen density for discriminating prostate cancer from benign prostatic hyperplasia in the gray zone of prostate-specific antigen.
    Uno H, Koide T, Kuriyama M, Ban Y, Deguchi T, Kawada Y.
    Hinyokika Kiyo; 1999 Jul; 45(7):457-61. PubMed ID: 10466060
    [Abstract] [Full Text] [Related]

  • 6. Ratio of alpha 1-antichymotrypsin--prostate specific antigen to total prostate specific antigen in prostate cancer diagnosis.
    Lein M, Jung K, Elgeti U, Brux B, Sinha P, Schnorr D, Loening SA.
    Anticancer Res; 2000 Jul; 20(6D):4997-5001. PubMed ID: 11326657
    [Abstract] [Full Text] [Related]

  • 7. [The percentage of free prostate specific antigen used in detecting prostate cancer].
    Yang L, Fang Z, Song J, Deng S.
    Zhonghua Wai Ke Za Zhi; 1999 Jan; 37(1):47-9. PubMed ID: 11829778
    [Abstract] [Full Text] [Related]

  • 8. Differential percentage of serum prostate-specific antigen subforms suggests a new way to improve prostate cancer diagnosis.
    Sarrats A, Comet J, Tabarés G, Ramírez M, Aleixandre RN, de Llorens R, Peracaula R.
    Prostate; 2010 Jan 01; 70(1):1-9. PubMed ID: 19670261
    [Abstract] [Full Text] [Related]

  • 9. The clinical value of the Enzymun-Test for total and free PSA--a multicentre evaluation.
    Reiter W.
    Anticancer Res; 1999 Jan 01; 19(6C):5559-62. PubMed ID: 10697616
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prostate specific antigen in benign prostatic hyperplasia: purification and characterization.
    Chen Z, Chen H, Stamey TA.
    J Urol; 1997 Jun 01; 157(6):2166-70. PubMed ID: 9146608
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The usefulness of serum human kallikrein 11 for discriminating between prostate cancer and benign prostatic hyperplasia.
    Nakamura T, Scorilas A, Stephan C, Jung K, Soosaipillai AR, Diamandis EP.
    Cancer Res; 2003 Oct 01; 63(19):6543-6. PubMed ID: 14559849
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterization and determination of the complex between prostate-specific antigen and alpha 1-protease inhibitor in benign and malignant prostatic diseases.
    Zhang WM, Finne P, Leinonen J, Stenman UH.
    Scand J Clin Lab Invest Suppl; 2000 Oct 01; 233():51-8. PubMed ID: 11317942
    [Abstract] [Full Text] [Related]

  • 18. [Changes of serum total PSA and free PSA in patients with prostate carcinoma and benign prostate hyperplasia].
    Gao ZW, Liu G, Sheng BW.
    Ai Zheng; 2004 Jun 01; 23(6):701-3. PubMed ID: 15191675
    [Abstract] [Full Text] [Related]

  • 19. Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer.
    Romppanen J, Haapalainen T, Punnonen K, Penttilä I.
    Anticancer Res; 2002 Jun 01; 22(1A):415-20. PubMed ID: 12017325
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.